Your browser doesn't support javascript.
loading
Geographic variation of mutagenic exposures in kidney cancer genomes.
Senkin, Sergey; Moody, Sarah; Díaz-Gay, Marcos; Abedi-Ardekani, Behnoush; Cattiaux, Thomas; Ferreiro-Iglesias, Aida; Wang, Jingwei; Fitzgerald, Stephen; Kazachkova, Mariya; Vangara, Raviteja; Le, Anh Phuong; Bergstrom, Erik N; Khandekar, Azhar; Otlu, Burçak; Cheema, Saamin; Latimer, Calli; Thomas, Emily; Atkins, Joshua Ronald; Smith-Byrne, Karl; Cortez Cardoso Penha, Ricardo; Carreira, Christine; Chopard, Priscilia; Gaborieau, Valérie; Keski-Rahkonen, Pekka; Jones, David; Teague, Jon W; Ferlicot, Sophie; Asgari, Mojgan; Sangkhathat, Surasak; Attawettayanon, Worapat; Swiatkowska, Beata; Jarmalaite, Sonata; Sabaliauskaite, Rasa; Shibata, Tatsuhiro; Fukagawa, Akihiko; Mates, Dana; Jinga, Viorel; Rascu, Stefan; Mijuskovic, Mirjana; Savic, Slavisa; Milosavljevic, Sasa; Bartlett, John M S; Albert, Monique; Phouthavongsy, Larry; Ashton-Prolla, Patricia; Botton, Mariana R; Silva Neto, Brasil; Bezerra, Stephania Martins; Curado, Maria Paula; Zequi, Stênio de Cássio.
Afiliación
  • Senkin S; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Moody S; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK.
  • Díaz-Gay M; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.
  • Abedi-Ardekani B; Department of Bioengineering, University of California San Diego, La Jolla, CA, USA.
  • Cattiaux T; Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.
  • Ferreiro-Iglesias A; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Wang J; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Fitzgerald S; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Kazachkova M; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK.
  • Vangara R; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK.
  • Le AP; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.
  • Bergstrom EN; Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.
  • Khandekar A; Biomedical Sciences Graduate Program, University of California San Diego, La Jolla, CA, USA.
  • Otlu B; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.
  • Cheema S; Department of Bioengineering, University of California San Diego, La Jolla, CA, USA.
  • Latimer C; Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.
  • Thomas E; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK.
  • Atkins JR; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.
  • Smith-Byrne K; Department of Bioengineering, University of California San Diego, La Jolla, CA, USA.
  • Cortez Cardoso Penha R; Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.
  • Carreira C; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.
  • Chopard P; Department of Bioengineering, University of California San Diego, La Jolla, CA, USA.
  • Gaborieau V; Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.
  • Keski-Rahkonen P; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.
  • Jones D; Department of Bioengineering, University of California San Diego, La Jolla, CA, USA.
  • Teague JW; Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.
  • Ferlicot S; Department of Health Informatics, Graduate School of Informatics, Middle East Technical University, Ankara, Turkey.
  • Asgari M; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK.
  • Sangkhathat S; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK.
  • Attawettayanon W; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK.
  • Swiatkowska B; Cancer Epidemiology Unit, The Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Jarmalaite S; Cancer Epidemiology Unit, The Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Sabaliauskaite R; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Shibata T; Evidence Synthesis and Classification Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Fukagawa A; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Mates D; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Jinga V; Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Rascu S; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK.
  • Mijuskovic M; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK.
  • Savic S; Service d'Anatomie Pathologique, Assistance Publique-Hôpitaux de Paris, Univeristé Paris-Saclay, Le Kremlin-Bicêtre, France.
  • Milosavljevic S; Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Bartlett JMS; Hasheminejad Kidney Center, Iran University of Medical Sciences, Tehran, Iran.
  • Albert M; Translational Medicine Research Center, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand.
  • Phouthavongsy L; Division of Urology, Department of Surgery, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand.
  • Ashton-Prolla P; Department of Environmental Epidemiology, Nofer Institute of Occupational Medicine, Lódz, Poland.
  • Botton MR; Laboratory of Genetic Diagnostic, National Cancer Institute, Vilnius, Lithuania.
  • Silva Neto B; Department of Botany and Genetics, Institute of Biosciences, Vilnius University, Vilnius, Lithuania.
  • Bezerra SM; Laboratory of Genetic Diagnostic, National Cancer Institute, Vilnius, Lithuania.
  • Curado MP; Laboratory of Molecular Medicine, The Institute of Medical Science, The University of Tokyo, Minato-ku, Japan.
  • Zequi SC; Division of Cancer Genomics, National Cancer Center Research Institute, Chuo-ku, Japan.
Nature ; 629(8013): 910-918, 2024 May.
Article en En | MEDLINE | ID: mdl-38693263
ABSTRACT
International differences in the incidence of many cancer types indicate the existence of carcinogen exposures that have not yet been identified by conventional epidemiology make a substantial contribution to cancer burden1. In clear cell renal cell carcinoma, obesity, hypertension and tobacco smoking are risk factors, but they do not explain the geographical variation in its incidence2. Underlying causes can be inferred by sequencing the genomes of cancers from populations with different incidence rates and detecting differences in patterns of somatic mutations. Here we sequenced 962 clear cell renal cell carcinomas from 11 countries with varying incidence. The somatic mutation profiles differed between countries. In Romania, Serbia and Thailand, mutational signatures characteristic of aristolochic acid compounds were present in most cases, but these were rare elsewhere. In Japan, a mutational signature of unknown cause was found in more than 70% of cases but in less than 2% elsewhere. A further mutational signature of unknown cause was ubiquitous but exhibited higher mutation loads in countries with higher incidence rates of kidney cancer. Known signatures of tobacco smoking correlated with tobacco consumption, but no signature was associated with obesity or hypertension, suggesting that non-mutagenic mechanisms of action underlie these risk factors. The results of this study indicate the existence of multiple, geographically variable, mutagenic exposures that potentially affect tens of millions of people and illustrate the opportunities for new insights into cancer causation through large-scale global cancer genomics.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Exposición a Riesgos Ambientales / Geografía / Neoplasias Renales / Mutágenos / Mutación Límite: Female / Humans / Male País/Región como asunto: Asia / Europa Idioma: En Revista: Nature Año: 2024 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Exposición a Riesgos Ambientales / Geografía / Neoplasias Renales / Mutágenos / Mutación Límite: Female / Humans / Male País/Región como asunto: Asia / Europa Idioma: En Revista: Nature Año: 2024 Tipo del documento: Article País de afiliación: Francia